Identification of novel Leishmania major antigens that elicit IgG2a response in resistant and susceptible mice
Mohammad Reza Mohammadi, Majid Zeinali, Sussan K. Ardestani, Amina Kariminia
Korean J Parasito. 2006;44(1):43-48. Published online 2006 Mar 20 DOI: https://doi.org/10.3347/kjp.2006.44.1.43
Citations to this article as recorded by 
Immunological characterization of rLdTCP1γ for its prophylactic potential against visceral leishmaniasis in hamster model
Apeksha Anand, Deep Chandra Balodi, Karthik Ramalingam, Shailendra Yadav, Neena Goyal
Molecular Immunology.2022; 141: 33. CrossRef
Adjuvanted vaccines driven protection against visceral infection in BALB/c mice by Leishmania donovani
Deepak Kumar Goyal, Poonam Keshav, Sukhbir Kaur
Microbial Pathogenesis.2021; 151: 104733. CrossRef
Immune induction by adjuvanted Leishmania donovani vaccines against the visceral leishmaniasis in BALB/c mice
Deepak Kumar Goyal, Poonam Keshav, Sukhbir Kaur
Immunobiology.2021; 226(2): 152057. CrossRef
Adjuvant effects of TLR agonist gardiquimod admixed with Leishmania vaccine in mice model of visceral leishmaniasis
Deepak Kumar Goyal, Poonam Keshav, Sukhbir Kaur
Infection, Genetics and Evolution.2021; 93: 104947. CrossRef
The potential of live attenuated vaccines against Cutaneous Leishmaniasis
A. Zabala-Peñafiel, D. Todd, H. Daneshvar, R. Burchmore
Experimental Parasitology.2020; 210: 107849. CrossRef
Immunization with a recombinant fusion protein protects mice against Helicobacter pylori infection
Amir Ghasemi, Nazanin Mohammad, Josef Mautner, Mehrnaz Taghipour Karsabet, Jafar Amani, Abolfazl Ardjmand, Zarichehr Vakili
Vaccine.2018; 36(34): 5124. CrossRef
Evaluation of vaccinal effectiveness of preparations containing membrane antigens of Leishmania (L.) amazonensis in experimental cutaneous leishmaniasis model
João G. Ribeiro, Amália S. Ferreira, Sharon R.A. Macedo, Norton R.D.L.P. Rossi, Mayara C.P. da Silva, Rosane N.M. Guerra, Neuza B. de Barros, Roberto Nicolete
International Immunopharmacology.2017; 47: 227. CrossRef
Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis
Ankita Thakur, Harpreet Kaur, Sukhbir Kaur
Parasitology International.2015; 64(1): 70. CrossRef
Ox40L–Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major
Rashmi Tuladhar, Steve Oghumu, Ran Dong, Allison Peterson, Arlene H. Sharpe, Abhay R. Satoskar
Experimental Parasitology.2015; 148: 49. CrossRef
Identification of immunodominant Leishmania major antigenic markers of the early C57BL/6 and BALB/c mice infection stages
A. Sassi, O. Kaak, A. Ben Ammar Elgaied
Parasite Immunology.2015; 37(10): 544. CrossRef
Th1 Platform Immune Responses Against Leishmania major Induced by Thiol-Specific Antioxidant-Based DNA Vaccines
Fatemeh Tabatabaie, Mehdi Mahdavi, Sobhan Faezi, Abdolhossein Dalimi, Zohreh Sharifi, Lame Akhlaghi, Fatemeh Ghaffarifar
Jundishapur Journal of Microbiology.2014;[Epub] CrossRef
Studies on the protective efficacy and immunogenicity of Hsp70 and Hsp83 based vaccine formulations in Leishmania donovani infected BALB/c mice
Jaspreet Kaur, Tejinder Kaur, Sukhbir Kaur
Acta Tropica.2011; 119(1): 50. CrossRef
Protective effect of lectin from Synadenium carinatum on Leishmania amazonensis infection in BALB/c mice
Sandra R. Afonso-Cardoso, Flávio H. Rodrigues, Márcio A.B. Gomes, Adriano G. Silva, Ademir Rocha, Aparecida H.B. GuimarÃes, Ignês Candeloro, Sílvio Favoreto, Marcelo S. Ferreira, Maria A. de Souza
The Korean Journal of Parasitology.2007; 45(4): 255. CrossRef
Purification and biochemical characterization of two novel antigens from Leishmania major promastigotes
Majid Zeinali, Sussan K. Ardestani, Amina Kariminia
The Korean Journal of Parasitology.2007; 45(4): 287. CrossRef